South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde最新文献

筛选
英文 中文
Consent for critical care research after death from COVID-19: Arguments for a waiver. COVID-19死亡后重症监护研究的同意:放弃的理由。
IF 2.2
K Moodley, B W Allwood, T M Rossouw
{"title":"Consent for critical care research after death from COVID-19: Arguments for a waiver.","authors":"K Moodley,&nbsp;B W Allwood,&nbsp;T M Rossouw","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Pandemics challenge clinicians and scientists in many ways, especially when the virus is novel and disease expression becomes variable or unpredictable. Under such circumstances, research becomes critical to inform clinical care and protect future patients. Given that severely ill patients admitted to intensive care units are at high risk of mortality, establishing the cause of death at a histopathological level could prove invaluable in contributing to the understanding of COVID-19. Postmortem examination including autopsies would be optimal. However, in the context of high contagion and limited personal protective equipment, full autopsies are not being conducted in South Africa (SA). A compromise would require tissue biopsies and samples to be taken immediately after death to obtain diagnostic information, which could potentially guide care of future patients, or generate hypotheses for finding needed solutions. In the absence of an advance written directive (including a will or medical record) providing consent for postmortem research, proxy consent is the next best option. However, obtaining consent from distraught family members, under circumstances of legally mandated lockdown when strict infection control measures limit visitors in hospitals, is challenging. Their extreme vulnerability and emotional distress make full understanding of the rationale and consent process difficult either before or upon death of a family member. While it is morally distressing to convey a message of death telephonically, it is inhumane to request consent for urgent research in the same conversation. Careful balancing of the principles of autonomy, non-maleficence and justice becomes an ethical imperative. Under such circumstances, a waiver of consent, preferably followed by deferred proxy consent, granted by a research ethics committee in keeping with national ethics guidance and legislation, would fulfil the basic premise of care and research: first do no harm. This article examines the SA research ethics framework, guidance and legislation to justify support for a waiver of consent followed by deferred proxy consent, when possible, in urgent research after death to inform current and future care to contain the pandemic in the public interest.</p>","PeriodicalId":520778,"journal":{"name":"South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde","volume":" ","pages":"629-634"},"PeriodicalIF":2.2,"publicationDate":"2020-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38340983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Freedom of speech and public interest, not allegiance, should underpin science advisement to government. 言论自由和公共利益,而不是忠诚,应该成为科学向政府提供建议的基础。
IF 2.2
J A Singh, A Habib, J Jansen
{"title":"Freedom of speech and public interest, not allegiance, should underpin science advisement to government.","authors":"J A Singh,&nbsp;A Habib,&nbsp;J Jansen","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":520778,"journal":{"name":"South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde","volume":" ","pages":"578-580"},"PeriodicalIF":2.2,"publicationDate":"2020-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38436694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Statement of support for Professor Glenda Gray and the principle of academic freedom of speech. 支持格伦达·格雷教授和学术言论自由原则的声明。
IF 2.2
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde Pub Date : 2020-05-25 DOI: 10.7196/SAMJ.2020.v110i7.14964
F Venter
{"title":"Statement of support for Professor Glenda Gray and the principle of academic freedom of speech.","authors":"F Venter","doi":"10.7196/SAMJ.2020.v110i7.14964","DOIUrl":"https://doi.org/10.7196/SAMJ.2020.v110i7.14964","url":null,"abstract":"","PeriodicalId":520778,"journal":{"name":"South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde","volume":" ","pages":"555-560"},"PeriodicalIF":2.2,"publicationDate":"2020-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.7196/SAMJ.2020.v110i7.14964","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38340118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How should health resource allocation be applied during the COVID-19 pandemic in South Africa? 在南非2019冠状病毒病大流行期间,卫生资源应如何分配?
IF 2.2
A Taylor, B Taylor, J Parkes, J J Fagan
{"title":"How should health resource allocation be applied during the COVID-19 pandemic in South Africa?","authors":"A Taylor,&nbsp;B Taylor,&nbsp;J Parkes,&nbsp;J J Fagan","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":520778,"journal":{"name":"South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde","volume":" ","pages":"12950"},"PeriodicalIF":2.2,"publicationDate":"2020-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38340116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A policy and decision-making framework for South African doctors during the COVID-19 pandemic. COVID-19大流行期间南非医生的政策和决策框架。
IF 2.2
K Jones-Bonofiglio, N Nortjé
{"title":"A policy and decision-making framework for South African doctors during the COVID-19 pandemic.","authors":"K Jones-Bonofiglio,&nbsp;N Nortjé","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Faced with a pandemic, doctors around the world are forced to make difficult ethical decisions about clinical, economic and politically charged issues in medicine and healthcare, with little time or resources for support. A decision-making framework is suggested to guide policy and clinical practice to support the needs of healthcare workers, help to allocate scarce resources equitably and promote communication among stakeholders, while drawing on South African doctors' knowledge, culture and experience.</p>","PeriodicalId":520778,"journal":{"name":"South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde","volume":" ","pages":"613-616"},"PeriodicalIF":2.2,"publicationDate":"2020-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38340981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What are we doing to the children of South Africa under the guise of COVID-19 lockdown? 在COVID-19封锁的幌子下,我们对南非的儿童做了什么?
IF 2.2
L Van Bruwaene, F Mustafa, J Cloete, A Goga, R J Green
{"title":"What are we doing to the children of South Africa under the guise of COVID-19 lockdown?","authors":"L Van Bruwaene,&nbsp;F Mustafa,&nbsp;J Cloete,&nbsp;A Goga,&nbsp;R J Green","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":520778,"journal":{"name":"South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde","volume":" ","pages":"574-575"},"PeriodicalIF":2.2,"publicationDate":"2020-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38436692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ending HIV/AIDS: Not as close as many would have us believe. 终结艾滋病毒/艾滋病:并不像许多人让我们相信的那样接近。
IF 2.2
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde Pub Date : 2020-01-30 DOI: 10.7196/10.7196/SAMJ.2020.v110i2.14526
M J Rotheram-Borus, S Gordon, J Christodoulou, M Tomlinson
{"title":"Ending HIV/AIDS: Not as close as many would have us believe.","authors":"M J Rotheram-Borus,&nbsp;S Gordon,&nbsp;J Christodoulou,&nbsp;M Tomlinson","doi":"10.7196/10.7196/SAMJ.2020.v110i2.14526","DOIUrl":"https://doi.org/10.7196/10.7196/SAMJ.2020.v110i2.14526","url":null,"abstract":"","PeriodicalId":520778,"journal":{"name":"South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde","volume":" ","pages":"12848"},"PeriodicalIF":2.2,"publicationDate":"2020-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.7196/10.7196/SAMJ.2020.v110i2.14526","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38147281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Parents refusing blood transfusions for their children solely on religious grounds: Who must apply for the court order? 仅以宗教理由拒绝为孩子输血的父母:谁必须申请法院命令?
IF 2.2
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde Pub Date : 2020-01-30 DOI: 10.7196/10.7196/SAMJ.2020.v110i2.14486
D J McQuoid-Mason
{"title":"Parents refusing blood transfusions for their children solely on religious grounds: Who must apply for the court order?","authors":"D J McQuoid-Mason","doi":"10.7196/10.7196/SAMJ.2020.v110i2.14486","DOIUrl":"https://doi.org/10.7196/10.7196/SAMJ.2020.v110i2.14486","url":null,"abstract":"<p><p>The South African Constitution provides that children have the right to healthcare, as well as all other rights. Furthermore, in all matters affecting them, their best interests must be 'of paramount importance'. It seems common practice that, when parents refuse blood transfusions for their children solely on religious grounds, doctors and health authorities apply for a court order to overturn such refusals. However, since the implementation of the Children's Act of 2005, it may be that the onus is no longer on doctors and authorities to apply to court to reverse the decision of parents and guardians. It can be argued instead that the burden has shifted to the parents to apply to court for an order to overrule the decision of doctors, by proving to the court that alternative choices are available. Guidance is given for situations, particularly in the public sector, where alternative choices are not available.</p>","PeriodicalId":520778,"journal":{"name":"South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde","volume":" ","pages":"100-101"},"PeriodicalIF":2.2,"publicationDate":"2020-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.7196/10.7196/SAMJ.2020.v110i2.14486","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38152746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Understanding the basics of cannabidiol from cannabis to apply to therapeutics in epilepsy. 了解大麻中大麻二酚的基础知识,应用于癫痫治疗。
IF 2.2
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde Pub Date : 2020-01-29 DOI: 10.7196/SAMJ.2020.v110i2.14410
L Hay
{"title":"Understanding the basics of cannabidiol from cannabis to apply to therapeutics in epilepsy.","authors":"L Hay","doi":"10.7196/SAMJ.2020.v110i2.14410","DOIUrl":"https://doi.org/10.7196/SAMJ.2020.v110i2.14410","url":null,"abstract":"The compounds present in cannabis have been in use for both recreational and medicinal purposes for many centuries. Changes in the legislation in South Africa have led to an increase in the number of people interested in using these compounds for self-medication. Many of them may approach their general practitioner as the first source of information about possible therapeutic effects. It is important that medical professionals are able to give patients the correct information. Cannabidiol (CBD) is one of the main compounds in cannabis plants, and there is evidence that it can successfully treat certain patients with epilepsy. This review looks at the most recent evidence on the use of CBD in the treatment of epilepsy and explores the mechanisms behind these beneficial effects.","PeriodicalId":520778,"journal":{"name":"South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde","volume":" ","pages":"102-105"},"PeriodicalIF":2.2,"publicationDate":"2020-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.7196/SAMJ.2020.v110i2.14410","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38152745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Direct-acting antiviral therapy for hepatitis C: The initial experience of the University of Cape Town/Groote Schuur Hospital Liver Clinic, South Africa. 丙型肝炎直接抗病毒治疗:南非开普敦大学/格鲁特舒尔医院肝脏诊所的初步经验
IF 2.2
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde Pub Date : 2020-01-29 DOI: 10.7196/SAMJ.2020.v110i2.14195
M W Sonderup, N Gogela, R Nordien, H Smuts, S Korsman, D Hardie, C W Spearman
{"title":"Direct-acting antiviral therapy for hepatitis C: The initial experience of the University of Cape Town/Groote Schuur Hospital Liver Clinic, South Africa.","authors":"M W Sonderup,&nbsp;N Gogela,&nbsp;R Nordien,&nbsp;H Smuts,&nbsp;S Korsman,&nbsp;D Hardie,&nbsp;C W Spearman","doi":"10.7196/SAMJ.2020.v110i2.14195","DOIUrl":"https://doi.org/10.7196/SAMJ.2020.v110i2.14195","url":null,"abstract":"BACKGROUND\u0000An estimated 600 000 South Africans are chronically infected with hepatitis C virus (HCV). To date, accurate prevalence data are lacking, but emerging data suggest a significant burden in key populations. Historically, pegylated interferon and ribavirin treatment was challenging, with access limited. The advent of all-oral, short-course direct-acting antiviral (DAA) therapy has revolutionised the management of HCV, being well tolerated and highly effective, although initial cost was a prohibitive factor.\u0000\u0000\u0000OBJECTIVES\u0000To report our initial 2-year experience with DAA therapy at the University of Cape Town/Groote Schuur Hospital Liver Clinic, South Africa (SA).\u0000\u0000\u0000METHODS\u0000Patients who were viraemic for HCV were offered access to DAA therapy. All relevant demographic, virological, serological and clinical laboratory data were captured in a registry. Liver fibrosis was assessed non-invasively with the FibroScan. DAA regimens were prescribed according to current guidance based on HCV genotype (GT), prior treatment history and degree of fibrosis. On treatment, virological response was recorded and a sustained virological response (SVR) was defined as an undetectable HCV RNA at least 12 weeks after the end of treatment.\u0000\u0000\u0000RESULTS\u0000We report on the first 210 patients treated. Their median (interquartile range (IQR)) age was 52 (42 - 61) years and 65% were male, with men significantly younger than women at 50 (42 - 59) years v. 58 (47 - 67) years, respectively (p=0.001). All GTs were observed, with 1 and 5 most prevalent at 45% and 20%, respectively, and GTs 2, 3 and 4 frequencies of 7%, 11% and 17%, respectively. Extensive subtype diversity for GTs 2 and 4 was present. The median (IQR) HCV viral load was log10 5.9 IU/mL (5.4 - 6.5). A significant proportion of patients (39%) had advanced fibrosis or cirrhosis, with 11% F3 fibrosis and 28% F4. Of those with cirrhosis, 12% were decompensated with Childs-Pugh B or C disease. Of the patients, 19% were HIV co-infected and 2% HBV co-infected. In total, 13% were treatment experienced. The majority of patients were treated with sofosbuvir and ledipasvir (38%), daclatasvir (36%) or velpatasvir (± voxilaprevir, 9%). Less frequent combinations included partitaprevir, ritonavir, ombitasvir ± dasbuvir (11%) and sofosbuvir/ribavirin (5%). The per-protocol SVR was 96% (98% if sofosbuvir/ribavirin is excluded). The majority of treatment failures occurred with GT-4, notably subtype 4r. Mild side-effects were reported in 10% of patients, with none discontinuing therapy.\u0000\u0000\u0000CONCLUSIONS\u0000DAA therapy for HCV in a pan-genotypic group of patients, many with advanced liver disease, was highly effective. Our outcomes correspond with existing trial and real-world data for similar treatment. DAA therapy and access need rapid upscaling in SA, especially targeting key populations at point of care.","PeriodicalId":520778,"journal":{"name":"South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde","volume":" ","pages":"112-117"},"PeriodicalIF":2.2,"publicationDate":"2020-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.7196/SAMJ.2020.v110i2.14195","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38152748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信